Utility of (18)fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
S Horwitz, B Coiffier, F Foss, HM Prince, L Sokol, M Greenwood, D Caballero, F Morschhauser, L Pinter-Brown, SP Iyer, A Shustov, J Nichols, J Balser, B Balser, B Pro
Annals of Oncology | OXFORD UNIV PRESS | Published : 2015
Awarded by NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
The GPI-06-0002 study was supported by funding from Celgene Corporation (no grant numbers apply).